期刊文献+

黄蜀葵花对慢性肾小球肾炎患者尿生化指标的影响 被引量:15

Abelmoschus Manihot's Effect on Urine Biochemical Parameter in Patients with Chronic Glomerulonephritis
下载PDF
导出
摘要 目的观察黄蜀葵花对慢性肾小球肾炎患者肾小管功能的影响,揭示其对肾小球疾病患者的肾小管保护作用。方法将我院2008年1月至2010年5月慢性肾小球肾炎住院患者229例纳入本研究,黄蜀葵花治疗组168例,对照组61例,观察2组患者治疗前后血清肌酐水平(Scr)、估算的肾小球滤过率(eGFR)、尿α1-微球蛋白(α1-MG)、尿N-乙酰-β-氨基葡萄糖苷酶(NAG)、尿比重(SG)等指标变化情况。结果治疗2个月后黄蜀葵花治疗组肾功能正常患者的尿α1-MG、NAG水平均较治疗前显著下降(P<0.05),尿SG水平较治疗前显著上升(P<0.05),黄蜀葵花治疗组轻度肾功能损害患者的尿α1-MG、NAG和Scr水平均较治疗前显著下降(P<0.05),eGFR较治疗前显著升高(P<0.05)。对照组较治疗前无明显变化(P>0.05),2组比较,P<0.05。结论黄蜀葵花可以降低慢性肾小球肾炎患者尿α1-MG、NAG水平,可以改善肾小管功能,延缓慢性肾衰竭进展。 OBJECTIVE To observe the effect of abelmoschu manihot on renal tubular function in patient with chronic glomerulonephritis,and reveal its protective function on renal tubules.METHODS 229 chronic glomerulonephritis patients in our hospital(from January in 2008 to May in 2010) were divided into two groups:treatment group(168 cases) and control group(61 cases).The levels of serum creatinine(Scr),estimated glomerular filtration rate(eGFR),urine α1 microglobuli(α1-MG),urine N-Acety1-β-glucosaminase(NAG) and urine specific gravity(SG) before and after the treatment were observed.RESULTS After two-month treatment,the levels of urine α1-MG and urine NAG of patients with normal renal function in treatment groups decreased significantly(P0.05) and urine SG increased significantly(P0.05).The levels of urine α1-MG,urine NAG and Scr of patients with slight renal function impairment decreased significantly(P0.05);the level of eGFR increased significantly(P0.05).There was no significant change(P0.05).CONCLUSION Abelmoschus manihot can reduce the levels of urine α1-MG,urine NAG of patients with chronic glomerulonephritis,improve the function of renal tubules and retard the progression of renal failure.
作者 刘锋 周广宇
出处 《南京中医药大学学报》 CAS CSCD 北大核心 2011年第3期293-294,共2页 Journal of Nanjing University of Traditional Chinese Medicine
关键词 黄蜀葵花 肾小球肾炎 肾小管间质 abelmoschus manihot glomerulonephritis tubulointerstitium
  • 相关文献

参考文献5

二级参考文献20

  • 1赵海霞.清氮灌肠液对腺嘌呤所致大鼠慢性肾衰竭模型的影响[J].中国中西医结合肾病杂志,2004,5(11):634-636. 被引量:2
  • 2刘强,马济民,候积寿.慢性肾衰动物模型的评价[J].国外医学(泌尿系统分册),1994,14(2):69-72. 被引量:12
  • 3张佩青,刘锂,乔会秀.肾衰保肾胶囊延缓腺嘌呤致大鼠慢性肾功能衰竭的实验研究[J].中医药学报,2007,35(1):22-24. 被引量:3
  • 4王效光 王亚莉.糖尿病肾病研究的最新进展[J].新医学,1999,30(12):720-720.
  • 5Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia:a delay of lethal cell injury in ischemic myocardium[J]. Circulation,1986,74(5): 1124.
  • 6Nakano A, Cohen MV, Downey JM. Ischemic preconditioning: from basic mechanisms to clinical applications[J]. Pharmacol Ther, 2000,86(3) :263.
  • 7Miki T, Cohen MV, Downey JM. Opioid receptor contributes to ischemic pre-conditioning through protein kinase C activation in rabbits[J]. Mol Cell Biochem, 1998,186(1-2):3.
  • 8Maulik N, Engelman RM, Rousou JA, et al. Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2[ J]. Circulation, 1999,100( 19 Suppl): Ⅱ369.
  • 9Anchez - Lozada LC-, Tapia E, Johnson RJ, et al. Glomerular hemodynamic changes associated with arteriolar lesions and tubulointerstitial inflammation. Kidney Int Suppl, 2003,86 : S9 - S14.
  • 10Vio CP,Jeanneret VA. Local induction of angiotensin- converting enzyme in the kidney as a mechanism of progressive renal diseases. Kidney Int Suppl, 2003,86 : S57 - S63.

共引文献137

同被引文献203

引证文献15

二级引证文献109

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部